18 hrs ago
Pacific Therapeutics Ltd. Issues Stock Options to Directors and Officers
The Company has issued a total of 525,000 options to purchase common shares to directors and officers under the 2013 stock option plan as approved at the Issuers previous annual general meeting.
Trending on the Topix Network
Wed Mar 05, 2014
RXi Pharmaceuticals granted patent for fibrosis treatment technology
RXi Pharmaceuticals granted patent for fibrosis treatment technology RXi Pharmaceuticals has been granted a patent by the USPTO on its unique self-delivering RNAi compounds, for the treatment of fibrosis.
Tue Mar 04, 2014
Proteostasis Therapeutics Announces Extension of Funded Collaboration ...
Proteostasis Therapeutics, Inc., a company developing novel therapeutics that regulate protein homeostasis to improve outcomes for patients with orphan and neurodegenerative diseases, today announced an extension of its funded collaboration with Cystic Fibrosis Foundation Therapeutics, Inc. , the non-profit drug discovery and development affiliate ... (more)
Mon Mar 03, 2014
Madi Vanstone, 12, seeks coverage for cystic fibrosis drug
A 12-year-old girl pleaded Monday for the Ontario government to cover the cost of an expensive drug to fight her rare disease.
Fri Feb 28, 2014
Miami New Times
Tomorrow: World of Beer in Dadeland Raises Money for Cystic Fibrosis
World of Beer-Dadeland celebrates its two-year anniversary tomorrow, but instead of receiving gifts, it is raising money for the Cystic Fibrosis Foundation .
Thu Feb 27, 2014
The Motley Fool
Instant Double Aftermath: Is InterMune Inc. In Play?
The company has a first-in-class idiopathic pulmonary fibrosis drug that just aced its phase 3 trial and has solid market potential, possibly up to half a billion dollars in annual sales.
Wed Feb 26, 2014
Galectin Therapeutics Secures U.S. Patent For Its Proprietary...
Galectin Therapeutics , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the U.S. Patent and Trademark Office issued patent number 8,658,787 to the Company for its application titled "Galacto-rhamnogalacturonate compositions for the treatment of non-alcoholic steatohepatitis and ... (more)
Broadway's Finest Gather To Raise Funds And Awareness For The Pulmonary Fibrosis Foundation
Julie Halston, Lindsay Mendez, Lucas Steele, Christina Bianco, Tony Yazbeck, Liz Callaway, Robert Creighton, Cady Huffman and Rashidra Scott join Emmy and Golden Globe nominated actor Tony Danza at the Fourth Annual Broadway Belts for PFF! /PRNewswire-USNewswire/ -- For the fourth consecutive year Broadway's best vocal talent appeared Monday night ... (more)
Capitan Student Council sells links for a cure
Capitan Student Council has adopted the Cystic Fibrosis Foundation as one of its community service projects.
Tue Feb 25, 2014
Cystic fibrosis treatment clears the way
Stabilising a mucus attacking enzyme with cross-links could allow it to be delivered orally to fight infections in cystic fibrosis patients.
Mon Feb 24, 2014
The Doings Weekly
Cystic Fibrosis Foundation hosts 17th annual Grand Chefs Gala
The Event: Over 900 persnickety foodies met their match at the Cystic Fibrosis Foundation's 17th annual Grand Chefs Gala on January 31 at the Fairmont Hotel Chicago where 50 top chefs and ptissiers plied the guests with gourmet nibbles.
Rare lung disease patient "Watch List" tracks impact of restricted access to only treatment option
Rare lung disease patient "Watch List" tracks impact of restricted access to only treatment option Rare lung disease patient "Watch List" tracks impact of restricted access to only treatment option since the Canadian Pulmonary Fibrosis Foundation first took its fight for access to treatment to Queen's Park.
Canadian patients with rare lung disease still dying without access to only treatment
Esbriet has been proven to slow the progression of this rare, debilitating and ultimately fatal lung disease that scars the lungs so severely, patients are no longer able to breathe.
Galectin Therapeutics Presents At Workshop
Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that the Company will present at the Nonalcoholic Steatohepatitis Workshop hosted by JMP Securities on Thursday, February 27, 2014 in New York, NY.
Sun Feb 23, 2014
Broadway Belts for PFF! Concert, With Lindsay Mendez, Cady Huffman...
The fourth annual Broadway Belts for PFF! , a benefit concert for The Pulmonary Fibrosis Foundation that is hosted by Julie Halston , is held Feb. 24 at 7 PM at Birdland Jazz Club.
Sat Feb 22, 2014
The City Wire
Funding Cystic Fibrosis research was the 7th annual Wine Opener goal
Artist Jane Davidian painted Bentonville Square, which later sold for $600 in the live auction.
Fri Feb 21, 2014
Researchers' new test for cystic fibrosis may lead to more treatments
Treatments for cystic fibrosis may be faster to develop with the use of a new test created by Stanford researchers.
U.S. Food and Drug Administration Approves KALYDECOa (ivacaftor)...
Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved a supplemental New Drug Application for KALYDECOTM for people with cystic fibrosis ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator gene.
Thu Feb 20, 2014
Gilead shifts cystic fibrosis treatment to CURx Pharma
Terms of the deal between the Foster City-based Gilead and San Diego's CURx were not disclosed.
Tue Feb 18, 2014
2/23: Ryes up against cystic fibrosis
Join the members of the Baltimore Bartenders' Guild for the "Ryes Up against Cystic Fibrosis" fundraiser, benefiting the Cystic Fibrosis Foundation of Maryland.